Prelude Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1805 |
|
|
2020
Q1 | – | Sell |
-626
| Closed | -$7K | – | 1727 |
|
|
2019
Q4 | $7K | Sell |
626
-76
| -11% | -$850 | ﹤0.01% | 1272 |
|
|
2019
Q3 | $3K | Sell |
702
-6
| -0.8% | -$26 | ﹤0.01% | 1105 |
|
|
2019
Q2 | $11K | Sell |
708
-2
| -0.3% | -$31 | ﹤0.01% | 1001 |
|
|
2019
Q1 | $18K | Buy |
710
+695
| +4,633% | +$17.6K | ﹤0.01% | 966 |
|
|
2018
Q4 | $0 | Sell |
15
-19,353
| -100% | – | ﹤0.01% | 1848 |
|
|
2018
Q3 | $569K | Buy |
19,368
+11,668
| +152% | +$343K | 0.03% | 316 |
|
|
2018
Q2 | $350K | Buy |
7,700
+2,548
| +49% | +$116K | 0.02% | 491 |
|
|
2018
Q1 | $272K | Buy |
5,152
+4,677
| +985% | +$247K | 0.02% | 535 |
|
|
2017
Q4 | $32K | Sell |
475
-7,492
| -94% | -$505K | ﹤0.01% | 913 |
|
|
2017
Q3 | $656K | Sell |
7,967
-9,769
| -55% | -$804K | 0.06% | 280 |
|
|
2017
Q2 | $1.66M | Buy |
17,736
+16,205
| +1,058% | +$1.52M | 0.16% | 126 |
|
|
2017
Q1 | $97K | Sell |
1,531
-4,473
| -75% | -$283K | 0.01% | 745 |
|
|
2016
Q4 | $267K | Buy |
+6,004
| New | +$267K | 0.03% | 442 |
|
|
2015
Q4 | – | Sell |
-3,806
| Closed | -$350K | – | 1670 |
|
|
2015
Q3 | $350K | Sell |
3,806
-5,044
| -57% | -$464K | 0.05% | 334 |
|
|
2015
Q2 | $778K | Hold |
8,850
| – | – | 0.11% | 203 |
|
|
2015
Q1 | $657K | Buy |
+8,850
| New | +$657K | 0.09% | 253 |
|